[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MXPA04002247A - Metodo para la preparacion de hexahidro-furo[2,3-b]furan-3-ol. - Google Patents

Metodo para la preparacion de hexahidro-furo[2,3-b]furan-3-ol.

Info

Publication number
MXPA04002247A
MXPA04002247A MXPA04002247A MXPA04002247A MXPA04002247A MX PA04002247 A MXPA04002247 A MX PA04002247A MX PA04002247 A MXPA04002247 A MX PA04002247A MX PA04002247 A MXPA04002247 A MX PA04002247A MX PA04002247 A MXPA04002247 A MX PA04002247A
Authority
MX
Mexico
Prior art keywords
furo
hexahydro
furan
preparation
relates
Prior art date
Application number
MXPA04002247A
Other languages
English (en)
Inventor
Rudolf Romanie Kesteleyn Bart
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8180908&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA04002247(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of MXPA04002247A publication Critical patent/MXPA04002247A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invencion se relaciona con un metodo para la preparacion de hexahidro-furo[2,3-b]furan-3-ol, asi como con novedosos intermediarios para usar en dicho metodo; mas especificamente, la invencion se relaciona con un metodo estereoselectivo para la preparacion de hexahidro-furo[2,3-b]furan-3-ol, y con un metodo que se presta para la elaboracion en escala industrial.
MXPA04002247A 2001-09-10 2002-09-06 Metodo para la preparacion de hexahidro-furo[2,3-b]furan-3-ol. MXPA04002247A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01203416 2001-09-10
PCT/EP2002/010062 WO2003022853A1 (en) 2001-09-10 2002-09-06 Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol

Publications (1)

Publication Number Publication Date
MXPA04002247A true MXPA04002247A (es) 2005-09-07

Family

ID=8180908

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04002247A MXPA04002247A (es) 2001-09-10 2002-09-06 Metodo para la preparacion de hexahidro-furo[2,3-b]furan-3-ol.

Country Status (28)

Country Link
US (1) US7126015B2 (es)
EP (1) EP1448567B1 (es)
JP (1) JP4521185B2 (es)
KR (1) KR100894673B1 (es)
CN (2) CN101172980B (es)
AP (1) AP1758A (es)
AR (1) AR036501A1 (es)
AT (1) ATE453648T1 (es)
AU (1) AU2002333809C1 (es)
BR (1) BRPI0212341B8 (es)
CA (1) CA2459168C (es)
CY (1) CY1109974T1 (es)
DE (1) DE60234952D1 (es)
DK (1) DK1448567T3 (es)
EA (1) EA010883B1 (es)
ES (1) ES2338538T3 (es)
HK (1) HK1068887A1 (es)
HR (1) HRP20040320B1 (es)
HU (1) HU229505B1 (es)
IL (2) IL160166A0 (es)
MX (1) MXPA04002247A (es)
NO (1) NO328934B1 (es)
NZ (1) NZ531641A (es)
PL (1) PL224030B1 (es)
PT (1) PT1448567E (es)
SI (1) SI21463B (es)
WO (1) WO2003022853A1 (es)
ZA (1) ZA200401501B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050261507A1 (en) * 2002-06-27 2005-11-24 Doan Brian D Preparation of stereoisomers of (3alpha/beta, 6alpha/beta)hexahydrofuro[2,3-b]furan-3-ol
EP1589018A4 (en) * 2002-12-27 2007-03-14 Sumitomo Chemical Co PROCESS FOR PRODUCING A DERIVATIVE OF HEXAHYDROFURANOL, INTERMEDIATE THEREOF AND PROCESS FOR PRODUCING THE SAME
RS51073B (sr) 2003-12-23 2010-10-31 Tibotec Pharmaceuticals Ltd. Proces za pripremanje (3r,3as,6ar)-heksahidrofuro│2,3-b│ furan-3-il (1s,2r)-3-││(4-aminofenil) sulfonil│(izobutil) amino │-1-benzil-2-hidroksipropilkarbamata
TWI383975B (zh) * 2004-03-31 2013-02-01 Tibotec Pharm Ltd 製備（３Ｒ，３ａＳ，６ａＲ）六氫-呋喃并〔２，３-ｂ〕呋喃-３-醇之方法
JP5549898B2 (ja) * 2006-03-31 2014-07-16 独立行政法人産業技術総合研究所 ５−ヒドロキシメチル−２−フルフラールの製造法
BRPI0718706B8 (pt) * 2006-11-09 2021-05-25 Janssen R & D Ireland métodos para a preparação de hexa-hidrofuro[2,3- b]furan-3-ol
CN101024646B (zh) * 2007-02-06 2010-07-14 启东东岳药业有限公司 4-甲氧基呋喃并呋喃-2-酮的纯化方法
WO2008132154A1 (en) 2007-04-27 2008-11-06 Tibotec Pharmaceuticals Ltd. Methods for the preparation of n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide derivatives
US8592487B2 (en) 2007-10-26 2013-11-26 Concert Pharmaceuticals, Inc. Deuterated darunavir
TWI482775B (zh) 2008-09-01 2015-05-01 Tibotec Pharm Ltd 用於製備（３ｒ，３ａｓ，６ａｒ）－六氫呋喃并〔２，３－ｂ〕呋喃－３－基（１ｓ，２ｒ）－３－〔〔（４－胺基苯基）磺醯基〕（異丁基）胺基〕－１－苯甲基－２－羥基丙基胺基甲酸酯之方法
EP2358198A4 (en) * 2008-10-24 2012-11-14 Concert Pharmaceuticals Inc HYDROXYETHYLAMINO SULFONAMIDE DERIVATIVES
US8921415B2 (en) 2009-01-29 2014-12-30 Mapi Pharma Ltd. Polymorphs of darunavir
US9062065B2 (en) 2009-10-30 2015-06-23 Lupin Limited Process for preparation of darunavir and darunavir ethanolate of fine particle size
CN102725295A (zh) 2010-01-28 2012-10-10 Mapi医药公司 制备达芦那韦和达芦那韦中间体的方法
LT2643326T (lt) 2010-11-23 2017-02-27 Mylan Laboratories, Limited (3r,3as,6ar)-heksahidrofuro[2,3-b]furan-3-olio gavimo būdas
US8802724B2 (en) 2010-11-30 2014-08-12 Purdue Research Foundation Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans
ES2969589T3 (es) 2012-07-24 2024-05-21 Laurus Labs Ltd Solvato de Propionato de Darunavir
ES2657227T3 (es) * 2012-08-09 2018-03-02 Sumitomo Chemical Company, Limited Método para producir un derivado de hexahidrofurofuranol
CN103864813B (zh) * 2012-12-18 2017-02-22 上海迪赛诺化学制药有限公司 一种合成六氢呋喃并[2,3‑b]呋喃‑3‑醇及其对映体的方法
US10633390B2 (en) * 2015-06-25 2020-04-28 Msn Laboratories Private Limited Process for the preparation of [(1S,2R)-3-[[(4-aminophenyl)sulfonyl] (2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-carbamic acid (3R,3AS,6AR)hexahydro furo [2,3-B]furan-3-YL ester and its amorphous form
WO2017041228A1 (zh) * 2015-09-08 2017-03-16 浙江九洲药业股份有限公司 六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法
CN107043385B (zh) * 2016-02-05 2019-07-09 成都博腾药业有限公司 一种制备地瑞那韦中间体的方法
US10407438B2 (en) 2016-10-27 2019-09-10 Gilead Sciences, Inc. Crystalline forms of darunavir
CN106928248B (zh) * 2017-02-04 2019-01-04 青岛科技大学 一种制备(3R,3aS,6aR)六氢呋喃并[2,3-b]呋喃-3-醇的方法
CN110272398B (zh) 2018-03-16 2022-11-29 江苏瑞科医药科技有限公司 六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法
CN114853774A (zh) * 2022-06-24 2022-08-05 盐城迪赛诺制药有限公司 一种达卢那韦关键中间体的制备方法
CN115557964A (zh) * 2022-10-18 2023-01-03 启东东岳药业有限公司 一种药物化合物的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU35543A1 (es) * 1980-10-09 1983-05-05 Hoffmann La Roche Prostaglandines
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5281420A (en) * 1992-05-19 1994-01-25 The Procter & Gamble Company Solid dispersion compositions of tebufelone
WO1994026749A1 (en) * 1993-05-14 1994-11-24 Merck & Co., Inc. Hiv protease inhibitors
ES2127938T3 (es) 1993-08-24 1999-05-01 Searle & Co Hidroxietilamino sulfonamidas utiles como inhibidores de proteasas retroviricas.
RU2089545C1 (ru) * 1994-09-28 1997-09-10 Ярославский государственный технический университет Способ получения 2-метил-2-этил-1,3-диоксолан-4-ил-метилметакрилата
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) * 1996-09-18 1998-03-19 Solvay Pharm Gmbh Die gastrointestinale Durchblutung fördernde Arzneimittel
CZ295207B6 (cs) * 1997-01-30 2005-06-15 Novartis Ag Tvrdá želatinová tobolka obsahující cyklosporin A
WO1999067254A2 (en) * 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof
US7470506B1 (en) * 1998-06-23 2008-12-30 The United States Of America As Represented By The Department Of Health And Human Services Fitness assay and associated methods
KR100336090B1 (ko) * 1998-06-27 2002-05-27 윤승원 오일, 지방산 또는 이들의 혼합물을 함유한 난용성 약물의 고형분산제제
DE19906310A1 (de) * 1999-02-16 2000-08-17 Solvay Pharm Gmbh Arzneimittel zur Behandlung von Bluthochdruck
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
DK1222192T3 (da) * 1999-10-06 2008-10-20 Tibotec Pharm Ltd Hexahydrofuro-2,3-b furan-3-yl-N-3-(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino-1-benzyl-2-hydroxypropyl-carbamat som retroviral proteaseinhibitor

Also Published As

Publication number Publication date
PL224030B1 (pl) 2016-11-30
ZA200401501B (en) 2005-07-27
HUP0402140A2 (hu) 2005-02-28
BR0212341A (pt) 2004-07-27
HK1068887A1 (en) 2005-05-06
EP1448567B1 (en) 2009-12-30
DK1448567T3 (da) 2010-04-26
EA200400430A1 (ru) 2004-08-26
CN101172980A (zh) 2008-05-07
DE60234952D1 (de) 2010-02-11
CY1109974T1 (el) 2014-09-10
US20040249175A1 (en) 2004-12-09
AU2002333809B8 (en) 2008-07-03
KR20040029425A (ko) 2004-04-06
CN1553915A (zh) 2004-12-08
HRP20040320B1 (hr) 2012-11-30
NO20041434L (no) 2004-06-10
IL160166A0 (en) 2004-07-25
JP4521185B2 (ja) 2010-08-11
KR100894673B1 (ko) 2009-04-24
CN100519561C (zh) 2009-07-29
WO2003022853A1 (en) 2003-03-20
CN101172980B (zh) 2011-11-16
CA2459168A1 (en) 2003-03-20
SI21463A (sl) 2004-10-31
AU2002333809C1 (en) 2009-02-05
NZ531641A (en) 2005-08-26
AU2002333809B9 (en) 2008-06-26
HRP20040320A2 (en) 2005-04-30
PT1448567E (pt) 2010-03-12
HU229505B1 (hu) 2014-01-28
CA2459168C (en) 2014-01-28
JP2005502707A (ja) 2005-01-27
AU2002333809B2 (en) 2008-02-28
BRPI0212341B1 (pt) 2019-04-02
AR036501A1 (es) 2004-09-15
US7126015B2 (en) 2006-10-24
NO328934B1 (no) 2010-06-21
AP1758A (en) 2007-07-30
EA010883B1 (ru) 2008-12-30
AP2004002981A0 (en) 2004-03-31
BRPI0212341B8 (pt) 2021-05-25
ATE453648T1 (de) 2010-01-15
HUP0402140A3 (en) 2007-05-29
ES2338538T3 (es) 2010-05-10
PL367817A1 (en) 2005-03-07
SI21463B (sl) 2011-08-31
IL160166A (en) 2012-05-31
EP1448567A1 (en) 2004-08-25

Similar Documents

Publication Publication Date Title
AP1758A (en) Method for the preparation of hexahydro-furo [2,3-b]furan-3-ol.
IL162461A0 (en) Polymorphs of clopidogrel hydrogensulfate
PL371930A1 (en) Synthesis of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
WO2004015085A3 (en) Method and compositions relating to 5’-chimeric ribonucleic acids
MXPA03008811A (es) Procedimiento para la preparacion de 4,6-diaminopirimido (5,4-d) pirimidinas.
WO2001060981A8 (en) Tooth progenitor cell and method for its production
WO2004004635A3 (en) Radiolabeled compounds and liposomes and their methods of making and using the same
GB0401741D0 (en) Method to improve the stability of dispersions of carbon
AU2003244727A1 (en) Novel podophyllotoxin derivatives, the production thereof and the use of the same in therapeutics
AU2001277815A1 (en) Method to determine the quality of eye-optics
AU2002239739A1 (en) Compositions, methods and kits relating to remodelin
AU2002241277A1 (en) Functional plant, promoter to be used for producing the functional plant and method of using the same
AU2003302682A1 (en) Method of increasing neutrophil production using 2,3-benzodiazepines
AU2002336564A1 (en) Method of enzyme production by microorganisms
AU2002235773A1 (en) Yeast strain for testing the geno- and cytotoxicity of complex environmental contamination
AU2001278512A1 (en) Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof
HUP0301500A3 (en) Method for the production of imidazo-(1,2-c)-benzodiazepines and intermediates in the production thereof
AU2001278703A1 (en) Process for the production of block copolymers, block copolymers produced by the process, and use of the copolymers
IL161800A (en) Method for the production of desclarithromycin and intermediate products and their use in the production of desclarithromycin
GB2371051B (en) Method of making non-polluting products
GB2415428B (en) Method to improve the stability of dispersions of carbon
SG90767A1 (en) Method of making non-polluting products
AU2002325450A1 (en) Method in the manufacture of steel
WO2001019982A3 (en) Micro-organisms, their use and method for producing d-amino acids
AU2002249431A1 (en) Improvements relating to bioreactors

Legal Events

Date Code Title Description
FG Grant or registration